Bigfoot Biomedical, a medical device company creating insulin delivery through the use of AI and automation announced it has raised $45 million in
By: Laurie Block, MS, RDN, CDE. Edited by: Suvarna Sheth. When it comes to making New Year’s resolutions it’s important to realize that change is
Novo Nordisk launched a handful of new insulin affordability offerings for people living in the U.S. The new offerings include: My$99Insulin:
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s Fiasp® (insulin aspart injection) 100 u/mL for use as a new mealtime
January is the month of the year that everyone is motivated to eat healthy, exercise and lose weight. But, controlling diabetes is important every
DexCom, Inc. has partnered with Tandem Diabetes Care in the UK, Sweden, Italy, and Spain to distribute the Dexcom G6 CGM System integrated with
The American Diabetes Association (ADA) released a new set of clinical standards that for the first time include the use of autonomous artificial
Just days after U.S. senators, Elizabeth Warren and Richard Blumenthal blasted Eli Lilly’s authorized generic program for insulins, claiming
Averitas Pharma, Inc., announced its supplemental New Drug Application (sNDA) for a new drug to treat neuropathic pain has been accepted by the U.S.
Eli Lilly and Company announced a global agreement to integrate DexCom, Inc. products into Lilly’s personalized diabetes management system,
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: